Micropep, the global leader in micropeptide technology, has raised $29 million Series B funding round along with its proprietary discovery platform, Krisalix. The funding round was led by Zebra Impact Ventures, and BPI Green Tech Investment.
Read also – [Funding News] GeoWealth Secures $18 Million Growth Funding Led by BlackRock
All existing investors, Fall Line Capital, FMC Ventures, Sofinnova Partners, Supernova Invest, and IRDI Capital Investissement also participated, bringing the company’s total funding to more than $51.8 million.
Read also – [Funding News] Archera Raises $17 Million Series B Funding
This new round of funding will help Micropep to finalize the regulatory studies of our first micropeptide molecule and continue expanding our pipeline of new micropeptide active ingredients. Micropep ambition is to become a global provider of new micropeptide active ingredients to industry, working hand in hand with partners to develop functional formulated solutions.
“Micropep’s pioneering micropeptide technology holds immense promise for revolutionizing agriculture sustainably,” said Lionel Artusio, General Partner, Zebra Impact Ventures. “By backing the Micropep team, we’re excited to contribute to the growth of Micropep as a leader in nature-inspired agricultural innovation, fostering a healthier planet for future generations.”
“At Fall Line, we are thrilled to reinvest in Micropep at this pivotal stage,” said Baptiste Tellier, Managing Director of Fall Line Capital. “Micropep is strategically positioned to pioneer new, environmentally safe crop protection products. Our renewed investment is driven by the impressive strides the company has made over the past few years. Notably, Micropep has maintained the field efficacy of its micropeptides while reducing doses in field trials and lowering biomanufacturing costs. The integration of advanced generative artificial intelligence tools into its discovery platform has also significantly shortened design turnaround time. These remarkable achievements underscore the tremendous potential of Micropep.”
With this Series B round, Micropep aims to accelerate its go-to-market strategy based on partnerships and to finalise the regulatory studies of its first bio-fungicide molecule while further developing its pipeline of micro-peptide active ingredients based on its Krisalix platform.
“This new round of funding, happening in a particularly complex financing environment, is a great mark of recognition of both the exceptional results we achieved so far at Micropep and the future potential of our micropeptide discovery platform and first active ingredients,” said Thomas Laurent, Chief Executive Officer and co-founder of Micropep. “We are pleased to welcome on board Zebra Impact Ventures and BPI Green Tech Investment to help us deliver on our mission to build more sustainable agriculture to protect global food production for future generations.”
About Micropep
Founded in 2016, Micropep is an innovative plant biotechnology company developing the next generation of biological crop protection solutions based on the incredible potential of micropeptides; short natural peptide molecules that target and regulate plant genes and proteins.
